Crossref
Serum tryptase levels in patients with post-acute COVID-19 syndrome
Bratislava Medical Journal · 2024
DOI: 10.4149/bll_2024_47 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bratislava Medical Journal, 2024. Verfasst von Ana Hadak und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Post-Acute COVID-19 Syndrome, COVID-19.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Post-Acute COVID-19 SyndromeCOVID-19HumansTryptasesMast Cells
Substanzen
Tryptases
Zitieren
APA
Hadak, A., Premec, D., Perkovic, M., Dolenec, V., Bozan, M., Nedeljkovic, V., Kelava, T., & Markovic, I. (2024). Serum tryptase levels in patients with post-acute COVID-19 syndrome. Bratislava Medical Journal. https://doi.org/10.4149/bll_2024_47
Vancouver
Hadak A, Premec D, Perkovic M, Dolenec V, Bozan M, Nedeljkovic V, et al. Serum tryptase levels in patients with post-acute COVID-19 syndrome. Bratislava Medical Journal. 2024. doi:10.4149/bll_2024_47
BibTeX
@article{Hadak2024,
author = {Hadak, Ana and Premec, Durdica and Perkovic, Marina and Dolenec, Vanja and Bozan, Marina and Nedeljkovic, Vanja and Kelava, Tomislav and Markovic, Ivan},
title = {Serum tryptase levels in patients with post-acute COVID-19 syndrome},
journal = {Bratislava Medical Journal},
year = {2024},
doi = {10.4149/bll_2024_47}
}
EUVIMED